1. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation
- Author
-
Cristina Bostan, Mona Harissi-Dagher, Andrei-Alexandru Szigiato, and Taylor Nayman
- Subjects
medicine.medical_specialty ,Visual acuity ,medicine.medical_treatment ,Prosthesis ,Corneal Diseases ,Cornea ,Prosthesis Implantation ,Cellular and Molecular Neuroscience ,Postoperative Complications ,medicine ,Long term outcomes ,Humans ,Retrospective Studies ,business.industry ,Medical record ,Prostheses and Implants ,Sensory Systems ,Surgery ,Ophthalmology ,Treatment surgery ,Artificial Organs ,Boston keratoprosthesis ,medicine.symptom ,business ,Ocular surface ,Follow-Up Studies - Abstract
Background/aimsTo compare long-term outcomes of primary versus secondary (postgraft failure) Boston keratoprosthesis type 1 (KPro) implantation.MethodsMedical records of patients at the Centre hospitalier de l’Université de Montréal having undergone KPro implantation between 2008 and 2017 were reviewed and included if they had a preoperative Snellen best-corrected visual acuity (BCVA) of 20/100 or worse and a minimum of 5 years of follow-up. Eighty-two eyes were separated into two cohorts (40 primary, 42 secondary KPro) and BCVA, complications and device retention were evaluated between groups.ResultsBCVA improved from baseline in both groups at each year; this was significant at all five postoperative years in the primary group and the first 3 years in the secondary group (pConclusionPrimary KPro yielded favourable long-term visual outcomes but had more complications and lower retention rates than secondary KPro, likely explained by preoperative indications. Primary device implantation represents a favourable option for patients for whom grafts are likely to fail.
- Published
- 2021
- Full Text
- View/download PDF